New cancer clinical trial: Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Published on: November 27, 2018 at 12:00PM
Condition:   Recurrent Head and Neck Cancer
Interventions:   Biological: Ad/PNP;   Drug: Fludarabine Phosphate
Sponsors:   PNP Therapeutics, Inc.;   Food and Drug Administration (FDA);   Stanford University;   Emory University
Not yet recruiting
https://ift.tt/2AtKS6p